Fundamental and Clinical Pharmacology · 2009 · 37 citations · 19 references
PharmacyPharmacokineticsPharmacologyKidney TransplantationRenal PharmacokineticsTransplant ImmunologyCorticosteroid Use In TransplantationDrug Interactions In TransplantationImmunosuppression In Kidney TransplantationMaintenance ImmunosuppressionTransplant PharmacokineticsTransplant PharmacologyMycophenolate PharmacokineticsMycophenolic Acid TherapyPharmacokinetics In TransplantationSirolimus InteractionsSirolimus PharmacokineticsTacrolimus ExposureTacrolimus InteractionsTacrolimus Pharmacokinetics
This study was conducted to evaluate time-dependent pharmacokinetic changes and drug interactions over the first 6 months after transplantation in kidney transplant recipients receiving tacrolimus (TAC), prednisone (PRED) and mycophenolate mofetil (MMF) or sirolimus (SRL). Pharmacokinetic assessments were carried out at day 7 and months 1, 3, and 6 in kidney transplant recipients receiving TAC plus PRED with either MMF (2 g/day, n = 13) or SRL (15 mg loading dose, 5 mg for 7 days followed by 2 mg/day, n = 12). There were no differences in the main demographic characteristics or in mean PRED doses during the first 6 months after transplant. From day 7 to month 6, there was a 65% increase in TAC dose corrected exposure (dose corrected area under the curve; AUC) in patients receiving MMF (P = 0.005) and a 59% increase in TAC dose corrected exposure in patients receiving SRL (P = 0.008). From day 7 to month 6, there was a 72% increase in mycophenolate dose corrected exposure (P = 0.001) and a 65% increase in SRL dose corrected exposure (P = 0.008). TAC dose corrected exposure was 23% lower in patients receiving SRL compared with MMF (P = 0.012) on average over the study period. PRED dose reduction was associated with increase in TAC (in patients receiving SRL, P = 0.040) and mycophenolic acid (MPA) (P = 0.070) drug exposures. Tercile distribution of TAC drug exposure showed a positive correlation with mean SRL exposures (P = 0.016). Conversely, tercile distribution of SRL drug exposure showed a positive correlation with mean TAC exposures (P = 0.004). Time-dependent increases in TAC, MPA and SRL drug exposures occur up to 6 months after transplantation. Drug-to-drug interactions indicate that intense therapeutic drug monitoring is required to avoid under- or over-immunosuppression.
19
Dirk Kuypers, Maarten Naesens, Séverine Vermeire et al. · Clinical Pharmacology & Therapeutics · 2005 · 185 citations